Enzyme Replacement Therapy During Pregnancy in Fabry Patients : Review of Published Cases of Live Births and a New Case of a Severely Affected Female with Fabry Disease and Pre-eclampsia Complicating Pregnancy.
暂无分享,去创建一个
[1] J. Sławek,et al. Alglucosidase alfa therapy for Pompe disease in pregnancy – Case report , 2017, Journal of the Neurological Sciences.
[2] John J. Mitchell,et al. Pregnancy in patients with mucopolysaccharidosis: a case series , 2016, Molecular genetics and metabolism reports.
[3] A. Hagège,et al. X‐chromosome inactivation in female patients with Fabry disease , 2016, Clinical genetics.
[4] Z. Bicik,et al. Safe and Successful Treatment With Agalsidase Beta During Pregnancy in Fabry Disease. , 2015, Iranian journal of kidney diseases.
[5] Dawn A. Laney,et al. A Retrospective Survey Studying the Impact of Fabry Disease on Pregnancy. , 2015, JIMD reports.
[6] J. Politei,et al. Histologic abnormalities of placental tissues in Fabry disease: a case report and review of the literature. , 2012, Human pathology.
[7] H. Blaszyk,et al. Fabry disease complicating pregnancy , 2010, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.
[8] E. Christensen,et al. The effect of progressive glomerular disease on megalin-mediated endocytosis in the kidney. , 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[9] C. Hollak,et al. Analysis of placental tissue in Fabry disease with and without enzyme replacement therapy. , 2010, Placenta.
[10] J. Politei. Treatment with agalsidase beta during pregnancy in Fabry disease , 2010, The journal of obstetrics and gynaecology research.
[11] P. Bruneval,et al. Uneventful pregnancy outcome after enzyme replacement therapy with agalsidase beta in a heterozygous female with Fabry disease: A case report. , 2010, European journal of medical genetics.
[12] H. Kölbl,et al. Enzyme replacement therapy with agalsidase alfa in pregnant women with Fabry disease. , 2009, European journal of obstetrics, gynecology, and reproductive biology.
[13] J. Oliveira,et al. Females with Fabry disease frequently have major organ involvement: lessons from the Fabry Registry. , 2008, Molecular genetics and metabolism.
[14] A. Zamudio,et al. An "uneventful" pregnancy. , 2006, Family medicine.
[15] J. M. Aerts,et al. Manifestations of Fabry disease in placental tissue , 2006, Journal of Inherited Metabolic Disease.
[16] C. Whybra,et al. Successful pregnancy outcome in a patient with Fabry disease receiving enzyme replacement therapy with agalsidase alfa , 2005, Journal of Inherited Metabolic Disease.
[17] A. Samueloff,et al. Pregnancies in Gaucher disease: a 5-year study. , 2004, American journal of obstetrics and gynecology.
[18] K. Macdermot,et al. Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier females , 2001, Journal of medical genetics.
[19] K. Wendrich,et al. Clinical manifestation in female Fabry disease patients. , 2001, Contributions to nephrology.
[20] H. Sakuraba,et al. [Fabry disease (alpha-galactosidase deficiency)]. , 1995, Ryoikibetsu shokogun shirizu.
[21] D. Wlody,et al. Hypertension in pregnancy. , 1992, The New England journal of medicine.
[22] M. Ferguson-Smith. Early prenatal diagnosis , 1991, Prenatal diagnosis.
[23] R. Desnick,et al. Structural organization of the human alpha-galactosidase A gene: further evidence for the absence of a 3' untranslated region. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[24] O. Tsutsumi,et al. Early prenatal diagnosis of inborn error of metabolism: a case report of a fetus affected with Fabry's disease. , 2010, Asia-Oceania journal of obstetrics and gynaecology.
[25] J. Kint. Fabry's Disease: Alpha-Galactosidase Deficiency , 1970, Science.
[26] W. Herrmann,et al. Determination of urinary testosterone and epitestosterone in men, women, and children. , 1968, Clinical chemistry.
[27] R. Brady,et al. Enzymatic abnormalities in diseases of sphingolipid metabolism. , 1967, Clinical chemistry.